← FDA Drug Approvals (Drugs@FDA)

JASCAYD

NDA · New Drug Application · Sponsor: BOEHRINGER INGELHEIM · Approved 2025-12-19

Drug application

FDA Application #

NDA220449

Application type

New Drug Application

Brand name

JASCAYD

Generic name

Nerandomilast

Active ingredients

NERANDOMILAST

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

BOEHRINGER INGELHEIM

First approval

2025-12-19

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown